Beijing Scitop Bio-tech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Operating Revenue	371.81	365.46	302.37	298.87	368.24	364.09
Other Revenue	0.27	0.46	0.43	0.37	0.93	0.52
Revenue	372.08	365.92	302.79	299.24	369.17	364.62
Revenue Growth	13.41%	20.85%	1.19%	-18.94%	1.25%	7.51%
Cost of Revenue	184.5	177.72	126.41	135.91	177.29	181.17
Gross Profit	187.59	188.2	176.38	163.33	191.88	183.45
Selling, General & Admin	80.93	71.32	67.9	58.03	56.86	63.26
Research & Development	41.18	35.71	36.33	34.19	22.09	27.15
Other Operating Expenses	4.73	5.57	5.27	4.92	3.76	3.06
Operating Expenses	129.52	115.64	106.35	98.94	83.43	93.81
Operating Income	58.06	72.56	70.03	64.39	108.45	89.64
Interest Expense	-0	-0.14	-0.25	-0.5	-0.41	-0.44
Interest & Investment Income	14.7	22.05	28.34	30.13	12.82	18.35
Other Non Operating Income (Expenses)	-0.44	-0.01	-0.03	-0.05	-0.05	-0.04
EBT Excluding Unusual Items	72.31	94.45	98.08	93.97	120.81	107.52
Gain (Loss) on Sale of Investments	2.89	1.62	2.01	1.26	0.17	1.55
Gain (Loss) on Sale of Assets	-0.01	-	0.65	0.03	-0.01	11.2
Asset Writedown	-0.02	-0.02	-0.31	-0	-0	-0.15
Other Unusual Items	6.03	7.78	8.39	6.78	4.69	4.06
Pretax Income	81.2	103.83	108.83	102.04	125.66	124.17
Income Tax Expense	2.79	9.31	14.47	8.56	15.76	14.63
Earnings From Continuing Operations	78.41	94.52	94.36	93.48	109.89	109.54
Net Income	78.41	94.52	94.36	93.48	109.89	109.54
Net Income to Common	78.41	94.52	94.36	93.48	109.89	109.54
Net Income Growth	-14.81%	0.17%	0.94%	-14.93%	0.32%	13.42%
Shares Outstanding (Basic)	259	263	262	267	224	222
Shares Outstanding (Diluted)	259	263	262	267	224	222
Shares Change	-1.37%	0.17%	-1.87%	19.09%	1.00%	16.50%
EPS (Basic)	0.30	0.36	0.36	0.35	0.49	0.49
EPS (Diluted)	0.30	0.36	0.36	0.35	0.49	0.49
EPS Growth	-13.63%	0%	2.86%	-28.57%	-0.67%	-2.65%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021
Free Cash Flow	-61.68	-172.68	-69.38	-71.21	64.28	42.7
Free Cash Flow Per Share	-0.24	-0.66	-0.27	-0.27	0.29	0.19
Dividend Per Share	0.100	0.100	0.150	0.150	0.200	0.333
Dividend Growth	-33.33%	-33.33%	0%	-25.00%	-39.99%	-10.02%
Gross Margin	50.42%	51.43%	58.25%	54.58%	51.98%	50.31%
Operating Margin	15.60%	19.83%	23.13%	21.52%	29.38%	24.59%
Profit Margin	21.07%	25.83%	31.16%	31.24%	29.77%	30.04%
Free Cash Flow Margin	-16.58%	-47.19%	-22.91%	-23.80%	17.41%	11.71%
EBITDA	95.66	105.21	94.91	82.87	125.09	104.55
EBITDA Margin	25.71%	28.75%	31.35%	27.69%	33.88%	28.68%
D&A For EBITDA	37.59	32.65	24.88	18.48	16.64	14.91
EBIT	58.06	72.56	70.03	64.39	108.45	89.64
EBIT Margin	15.60%	19.83%	23.13%	21.52%	29.38%	24.59%
Effective Tax Rate	3.44%	8.97%	13.30%	8.39%	12.55%	11.79%
Revenue as Reported	202.58	365.92	302.79	299.24	369.17	364.62
Advertising Expenses	-	19.85	18.08	19.22	7.92	9.94